U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia

AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or ...

Phunware Announces Election of Ed Lu to the Board of Directors

Seasoned Finance Executive and Strategic Technology Advisor toGuide Board Strategy Technology and Customer InitiativesAUSTIN, ...
Opinion

Microsoft: Not Immune To The Risk Of Overbuilding

With one of the largest capital budgets in the AI industry, Microsoft is not immune to the risk of overbuilding data center capacity. Read why MSFT is a Sell.